From November 6, 2023 to December 31, 2023, the company has repurchased 4,057,100 shares, representing 0.28% for CNY 61.58 million. With this, the company has completed the repurchase of 4,057,100 shares, representing 0.28% for CNY 61.58 million under the buyback announced on November 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.05 CNY | +1.33% | +5.59% | +9.41% |
Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
Apr. 19 | Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.41% | 3.26B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023.